Key data were withheld from the publication of the UK’s “REACT-2” antibody study [Republication] [Updated 25 August 2026]
Further criticism of the UK’s REACT-2 study: concerns about bias and lack of transparency regarding symptom data.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
